Key facts
- · Type: Amendment first sale 2019-08-15 · Amount sold: $3.32M · SEC filing
- · Type: New offering first sale 2019-08-15 · Amount sold: $2.37M · SEC filing
- · Type: Amendment first sale 2019-08-15 · Amount sold: $2.37M · SEC filing
Jersey City, NEW JERSEY
Biotechnology
3
$2.37M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-10-06 | Amendment first sale 2019-08-15 | $3.32M | — | details · SEC filing |
| 2023-08-22 | New offering first sale 2019-08-15 | $2.37M | — | SEC filing |
| 2023-08-22 | Amendment first sale 2019-08-15 | $2.37M | — | SEC filing |
What do you want to do with Xenon Ophthalmics Inc?
Who to contact
- Zeshan Khan — Executive Officer, Director
- Steve Susanibar — Executive Officer
- Robert Gilligan — Director
- Bruce Stark — Promoter
- David Singelyn — Director
- Round: Form D/A (amended) filed 2026-10-06
- Amount sold: $3.32M
- Industry: Biotechnology
- Based: Jersey City, NEW JERSEY
People listed
- Zeshan Khan — Executive Officer, Director
- Steve Susanibar — Executive Officer
- Robert Gilligan — Director
- Bruce Stark — Promoter
- David Singelyn — Director
- Filing: Form D/A (amended) filed 2026-10-06
- Amount sold: $3.32M
- Industry group: Biotechnology
- Based: Jersey City, NEW JERSEY
- Entity type: Corporation
We'll show it in your MentionFox inbox when Xenon Ophthalmics Inc raises, hires or launches. No email unless you switch it on.
Watch Xenon Ophthalmics Inc →Want the whole picture on Xenon Ophthalmics Inc?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Xenon Ophthalmics Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Xenon Ophthalmics Inc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
3 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from Xenon Ophthalmics Inc's own filings with the SEC. The people those filings name are on the team page.